Navigation Links
Why do preterm deliveries pose cardiovascular risks for moms?
Date:1/10/2011

s.

Holzman said the team then will compare the data of women who delivered full-term babies with women who delivered preterm; researchers also will examine whether any association may be modified by factors such as race, socioeconomic status or maternal depression.

"Research that uncovers pathways linking preterm delivery to a mother's cardiovascular risk can lead to new treatment strategies for both problems," Holzman said. "If we can identify mothers very early in the process, we may be able to delay or prevent the onset of cardiovascular disease."

The women in the original POUCH study were patients at 52 clinics in five Michigan communities; researchers collected biological samples in mid-trimester, including blood, saliva, urine, hair and vaginal fluid. The placentas also were examined for pathologic markers linked to preterm deliveries.

The women also underwent detailed interviews and answered questionnaires about their lifestyles, home situations, economic status and perceived discrimination.


'/>"/>

Contact: Jason Cody
codyja@msu.edu
517-432-0924
Michigan State University
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Depression during pregnancy can double risk of preterm delivery
2. Uncultured bacteria found in amniotic fluids of women who experience preterm births
3. Preterm birth: Magnesium sulphate cuts cerebral palsy risk
4. Effectiveness of progesterone in reducing preterm births may be altered by genetic predisposition
5. March of Dimes provides $2.7 million in new funding for preterm birth research
6. HPV vaccine may prevent preterm births
7. Brain malformations significantly associated with preterm birth, Wake Forest research shows
8. Yale researchers may have uncovered the mechanism by which progesterone prevents preterm birth
9. New research shows genes of pregnant women and their fetuses can increase the risk of preterm labor
10. Prepregnancy, obesity and gestational weight gain influence risk of preterm birth
11. March of Dimes provides $2.6 million in new funding for preterm birth research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Why do preterm deliveries pose cardiovascular risks for moms?
(Date:6/17/2015)... und GERMANTOWN, Maryland , June 17, ... ®   Produktlinie mit DNA-Tests verbessert den Analyseprozess ... QGEN ; Frankfurt Prime Standard: QIA) hat heute ... der Produktlinie Investigator ® ... eingeführt. Die neuen Kits zur Erstellung genetischer Fingerabdrücke bieten ...
(Date:6/16/2015)... YORK , June 16, 2015  With the ... world, security remains a top concern. The recent compromise ... confirms the need for strong authentication within government agencies. ... Token, a biometric one-time password (OTP) authenticator, has been ... Standards (FIPS) 140-2 Level 3 validation for tamper proofing. ...
(Date:6/15/2015)... , Jun. 15, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, announces that its ... showcased to media at Digital Experience! @ NYC June 18th. ... showcase of the latest innovation in technology to over 300 ... be held at the Metropolitan Pavilion in New ...
Breaking Biology News(10 mins):QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3
... the Donald Danforth Plant Science Center have received two ... Energy (DOE) to do research on novel energy initiatives. ... the largest ever received on the Danforth Campus. The ... is the largest the organization has ever received. ...
... 2009 ZenithSolar, an Israeli start-up company, launched its first ... concentrated photovoltaic (CPV) systems developed by Prof. David Faiman of ... ZenithSolar Video Faiman, who is chairman of ... Jacob Blaustein Institutes for Desert Research, believes the new system ...
... 4-28-09. InDevR, a small biotech company in Boulder, CO, ... the University of Colorado. The FluChip was invented by ... and the Centers for Disease Control and Prevention in an ... Rowlen, now the CEO of InDevR, said that InDevR ...
Cached Biology News:DOE makes largest Danforth Campus research award in history 2DOE makes largest Danforth Campus research award in history 3DOE makes largest Danforth Campus research award in history 4DOE makes largest Danforth Campus research award in history 5Ben-Gurion University research and technology used in new solar energy farm 2FluChip technology licensed to combat deadly flu virus 2
(Date:6/30/2015)... June 30, 2015 /PRNewswire/ - Resverlogix Corp. ("Resverlogix") ... shares of Resverlogix have approved the resolutions relating ... Limited of 5,600,000 units at a price of ... unit being comprised of one common share and ... of approximately CAD$15 million; and (ii) the amendment ...
(Date:6/30/2015)... June 30, 2015  Today, Americord Registry, one of the ... Andrew Horne , a partner at Kirkland & Ellis LLP, ... Logo - http://photos.prnewswire.com/prnh/20150630/226958LOGO   "We are ... Board," says Martin Smithmyer , CEO of Americord. "He ... career that will assist Americord,s growth and vision." ...
(Date:6/30/2015)... Oldsmar, FL (PRWEB) , ... June 30, 2015 , ... ... approximately 7.76% of Cryo-Cell’s currently outstanding common shares (including shares of unvested restricted stock). ... tender offer, the last sale price of Cryo-Cell’s shares reported on the OTCBB was ...
(Date:6/30/2015)... 30, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... medicine company focused on the development of autologous ... its Phase 1/2 clinical trial of RCT-01, being ... tendinosis, has been enrolled and their tissue biopsy ... RCT-01 is comprised of non-bulbar dermal sheath (NBDS) ...
Breaking Biology Technology:Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3Americord Registry Announces Andrew Horne as Advisory Board Member 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4
... Sept. 8 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.,(NYSE Amex: ... announced,that the first lot of PANFLU.1, its H1N1 vaccine, has ... Control of Pharmaceutical and,Biological Products and obtained the Certificate for ... ready for delivery. , The released ...
... , , NOVATO, Calif., Sept. 8 ... Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company update ... September 15, 2009 at 1:35 p.m. ET. , , ... conference call via the investor section of the BioMarin website, ...
... , , SANTA CLARA, Calif., Sept. 8 ... Board: APNO) today announced that they have entered into a ... Cell Biosciences for $1.50 per share or approximately $17.9 million ... analysis business to include a global infrastructure and a broad ...
Cached Biology Technology:Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine 2BioMarin to Present at the Morgan Stanley Healthcare Conference 2Cell Biosciences Signs Agreement to Acquire Alpha Innotech 2Cell Biosciences Signs Agreement to Acquire Alpha Innotech 3Cell Biosciences Signs Agreement to Acquire Alpha Innotech 4Cell Biosciences Signs Agreement to Acquire Alpha Innotech 5
... The user-friendly Eppendorf Thermomixer R ... preparations that require shaking, heating, and ... greatly expanded its application and temperature ... can each accommodate 24 micro test ...
Mouse monoclonal antibody raised against a partial recombinant PDE2A. NCBI Entrez Gene ID = PDE2A...
... Blocker Array II can be used ... against various proteins and sera that are ... carriers. The array contains spots for 19 ... Application: Determination of antibody crossreactivity and species ...
... for 1,464 array sample elements. , , ,Includes:, ... BSA in PBS (10X): 50 ml , INDIA HisProbe ... packs , 10% Tween-20: 2 x 10 ml ampules ... ml , SuperSignal West Pico Stable Peroxide: 2 ...
Biology Products: